Bilberry
Anthocyanin-rich berry; eye claims overstated, metabolic effects modest.
What is Bilberry?
Bilberry (Vaccinium myrtillus) is a longevity supplement used for antioxidant anthocyanin source. NutriDex grades the human evidence as Mixed. Bilberry is a wild European relative of the blueberry, prized for its dark anthocyanin pigments. Its most famous claim — sharper night vision — fails when tested properly: a systematic review found the four most rigorous RCTs were all negative. Cardiometabolic data are modest: a 2025 meta-analysis of bilberry trials found only a marginal HbA1c drop and a triglyceride effect, with no change in fasting glucose, total cholesterol, HDL, blood pressure or inflammation. A broader berry meta-analysis credited bilberry with small LDL reductions (~0.30 mmol/L) and HDL rises. An open-label post-heart-attack trial reported a 38 m gain in 6-minute walk distance and lower oxidized LDL. Small single trials suggest bilberry/pine-bark combos lower eye pressure and that extract improves tear secretion in dry eye. Overall the berry is a reasonable antioxidant food, but supplement claims outrun the evidence.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Night vision improvementSystematic review found the 4 most rigorous RCTs all negative; the classic night-vision claim is not supported. | Moderate | — no effect · negligible | 1 |
| LDL/HDL cholesterol16-RCT berry meta-analysis: LDL ~-0.30 mmol/L, HDL ~+0.12; small effects, bilberry pooled among berries. | Moderate | ↑ benefit · small | 1 |
| Glycaemic control (HbA1c/fasting glucose)2025 bilberry meta-analysis showed only marginal HbA1c drop (p=0.06), glucose unchanged; anthocyanin pooled data more favorable. | Mixed | ↔ mixed · small | 3 |
| TriglyceridesBilberry and broader anthocyanin meta-analyses report a triglyceride-lowering signal; modest and heterogeneous. | Preliminary | ↑ benefit · small | 2 |
| Dry-eye tear secretionSingle small (n=21) double-blind RCT improved Schirmer test; needs replication. | Preliminary | ↑ benefit | 1 |
| Intraocular pressureOne small RCT used a bilberry+pine-bark combo, so the effect is not attributable to bilberry alone. | Preliminary | ↑ benefit · small | 1 |